SCHEMBL30299161

SCHEMBL30299161

CCOC(=O)c1cc(O)c2ccc(Cl)cc2c1

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BCL2L1 Q07817 1/20 0.53
CA12 O43570 3/20 0.53
CA1 P00915 3/20 0.53
CA2 P00918 3/20 0.53
CA7 P43166 3/20 0.53
CA9 Q16790 3/20 0.53
CA14 Q9ULX7 3/20 0.53
PTPN11 Q06124 2/20 0.51
ALOX15 P16050 5/20 0.47
ESR1 P03372 1/20 0.45
ESR2 Q92731 1/20 0.45
HSD17B2 P37059 1/20 0.44
MAOB P27338 1/20 0.44
KDM4E B2RXH2 2/20 0.44
PTGES O14684 1/20 0.44
ALOX5 P09917 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13057633 0.85 BCL2L1 (0.56) BCL2L1CA12CA1CA2CA7
SCHEMBL16479443 0.84 CA12 (0.58) BCL2L1CA12CA1CA2CA7
SCHEMBL2635623 0.84 LMNA (0.51) BCL2L1CA12CA1CA2CA7
SCHEMBL4395647 0.83 LMNA (0.55) BCL2L1CA12CA1CA2CA7
SCHEMBL30299154 0.83 BCL2L1 (0.53) BCL2L1CA12CA1CA2CA7
SCHEMBL2805615 0.83 BCL2L1 (0.53) BCL2L1CA12CA1CA2CA7
SCHEMBL2932838 0.83 BCL2L1 (0.53) BCL2L1CA12CA1CA2CA7
SCHEMBL3771693 0.82 BCL2L1 (0.56) BCL2L1CA12CA1CA2CA7
SCHEMBL16474353 0.82 BCL2L1 (0.52) BCL2L1CA12CA1CA2CA7
SCHEMBL163865 0.81 CA12 (0.57) BCL2L1CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115151551-B Macrocyclic indole derivatives as MCL-1 inhibitors 詹森药业有限公司 2024-10-25 CN disclosed
EP-4107161-A1 MACROCYCLIC INDOLE DERIVATIVES AS INHIBITORS OF MCL-1 Janssen Pharmaceutica NV (BE) 2022-12-28 EP disclosed